Hydrocortisone-induced anti-inflammatory effects in immature human enterocytes depend on the timing of exposure

Samuli Rautava1, W Allan Walker2, Lei Lu3

  • 1Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland; Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts; and.

Insights

Hydrocortisone can reduce inflammation in the immature human gut, but its effectiveness against inflammatory insults like IL-1β and TNF-α depends on treatment timing. This finding is crucial for understanding corticosteroid use in infants.

Area of Science:

  • Gastroenterology
  • Neonatology
  • Immunology

Background:

  • Immature gut inflammation contributes to necrotizing enterocolitis (NEC) risk.
  • Prenatal corticosteroids may lower NEC, but postnatal dexamethasone has neurodevelopmental risks.
  • Understanding hydrocortisone's direct effects on the infant gut is critical.

Purpose of the Study:

  • To investigate hydrocortisone's role in gene expression and inflammation in immature human enterocytes.
  • To determine the time-dependent effects of hydrocortisone on intestinal cells.
  • To analyze hydrocortisone's impact on inflammatory responses to IL-1β and TNF-α.

Main Methods:

  • Utilized cDNA microarray to analyze time-dependent hydrocortisone effects on H4 cells.
  • Conducted fetal intestinal organ and cell culture experiments.
  • Induced inflammatory responses with IL-1β and TNF-α, measuring IL-8 and IL-6 secretion.

Main Results:

  • Hydrocortisone altered gene expression patterns in a time-dependent manner.
  • Significantly reduced IL-1β-induced IL-8 and IL-6 secretion in fetal ileum and H4 cells.
  • Inhibited IL-8 secretion in response to TNF-α when given concurrently, but not when given 48h prior.

Conclusions:

  • Hydrocortisone attenuates IL-1β-induced inflammation in the immature gut.
  • The timing of hydrocortisone administration influences its anti-inflammatory efficacy.
  • Provides a basis for understanding differential corticosteroid effects in neonates.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
613
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.9K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
126